Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Apr 6;4(1):vdac040. doi: 10.1093/noajnl/vdac040

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2022. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Figure 2. — Estimated survival by Kaplan-Meier method—newly diagnosed vs recurrent OS; newly diagnosed vs recurrent PFS. (A) OS from diagnosis to death in the newly diagnosed population; 12-month estimated survival was 40.0%. (B) OS from diagnosis to death in the recurrent disease population; 12-month estimated survival was 91.1%. (C) Time from the LITT procedure to disease progression in the newly diagnosed population; estimated 12-month PFS was 31.5%. (D) Time from the LITT procedure to disease progression in the recurrent population; estimated 12-month PFS was 16.4%. Abbreviations: LITT, laser interstitial thermal therapy; OS, overall survival; PFS, progression-free survival.